HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hisamitsu Nagase Selected Research

Zoxazolamine

7/2009Inhibitory effect of magnolol on Trp-P-2-induced DNA damage in various organs in mice.
7/2009Anti-clastogenic effect of magnolol-containing Hange-koboku-to, Dai-joki-to, Goshaku-san, and Magnoliae Cortex on benzo(a)pyrene-induced clastogenicity in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hisamitsu Nagase Research Topics

Disease

8Neoplasms (Cancer)
02/2007 - 05/2002
7Neoplasm Metastasis (Metastasis)
02/2006 - 05/2002
3Choriocarcinoma
01/2016 - 07/2009
3Ascites
05/2006 - 04/2002
2Anaphylaxis (Anaphylactic Shock)
01/2012 - 10/2010
2Paralysis (Palsy)
07/2009 - 07/2009
2Inflammation
11/2008 - 01/2008
1Breast Neoplasms (Breast Cancer)
06/2012
1Carcinoma (Carcinomatosis)
06/2012
1Fetal Death
06/2011
1Hemorrhage
10/2010
1Retinal Degeneration
10/2010
1Hypersensitivity (Allergy)
10/2010
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2008
1Brain Ischemia (Cerebral Ischemia)
02/2008
1Leukemia
01/2008
1Ganglion Cysts (Ganglion)
09/2006
1Fibrosarcoma
12/2003
1Lymphoma (Lymphomas)
09/2003
1Melanoma (Melanoma, Malignant)
09/2003

Drug/Important Bio-Agent (IBA)

7Autocrine Motility FactorIBA
05/2006 - 04/2002
3Immunoglobulin E (IgE)IBA
01/2012 - 01/2008
3magnololIBA
07/2009 - 12/2002
2AntigensIBA
01/2012 - 10/2010
2ZoxazolamineIBA
07/2009 - 07/2009
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
11/2008 - 01/2008
1Tin CompoundsIBA
01/2016
1ProgesteroneFDA LinkGeneric
01/2016
1OxidoreductasesIBA
01/2016
1Organotin CompoundsIBA
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
06/2012
1Tetrachlorodibenzodioxin (TCDD)IBA
06/2012
1DNA (Deoxyribonucleic Acid)IBA
06/2012
1OvalbuminIBA
01/2012
1red fluorescent proteinIBA
06/2011
1LuciferasesIBA
06/2011
1growth inhibitory factorIBA
10/2010
1Hemoglobins (Hemoglobin)IBA
10/2010
1Purine-Nucleoside PhosphorylaseIBA
10/2010
1Trichloroethylene (Trichloroethene)IBA
10/2010
1Environmental PollutantsIBA
10/2010
1Histamine (Histamine Dihydrochloride)FDA Link
10/2010
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
07/2009
1PPAR gammaIBA
07/2009
1phenyltinIBA
07/2009
1Trp-P-2IBA
07/2009
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
07/2009
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
07/2009
1ZincIBA
02/2008
1Propofol (Diprivan)FDA LinkGeneric
02/2008
1Edetic Acid (EDTA)FDA Link
02/2008
1dinitrophenyl-bovine serum albuminIBA
01/2008
1SolventsIBA
01/2008
1Bovine Serum AlbuminIBA
01/2008
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2007
1N-Methylaspartate (NMDA)IBA
09/2006
1AntibodiesIBA
12/2003
1Protein Kinase CIBA
12/2003
1Protein Kinases (Protein Kinase)IBA
12/2003
1Apoptosomes (Apoptosome)IBA
12/2003
1Phosphotransferases (Kinase)IBA
12/2003
1phosphatidylinositol 3-phosphateIBA
12/2003
1Caspase 9IBA
12/2003
1CaspasesIBA
12/2002
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2002
1autocrine motility factor receptorIBA
09/2002

Therapy/Procedure

1Kampo Medicine (Kampo)
07/2009
1Chemoprevention
10/2006
1Drug Therapy (Chemotherapy)
12/2003